ABSTRACT

COVID-19: U.S. Impact on Antimicrobial Resistance   [open pdf - 11MB]

From the Document: "CDC [Centers for Disease Control and Prevention] uses several data sources and systems to track antimicrobial resistance in the United States and abroad. Knowing where and how changes in resistance are occurring helps us find solutions to prevent spread and slow resistance, especially in outbreak responses. Recently, the United States has been building a solid foundation for public health preparedness to address antimicrobial resistance. [...] More resources are needed to continue establishing a resilient public health system that can maintain capacity to respond to antimicrobial resistance while also responding to other threats. Without an infrastructure and supply chains grounded in preparedness, critical antimicrobial resistance data will be delayed again when the next threat emerges. We must address gaps identified before the COVID-19 [coronavirus disease 2019] pandemic, including expanding the public health workforce, increasing local access to the best detection tools and technology, and expanding global lab capacities." This document includes charts, tables, and graphs to illustrate the text.

Author:
Publisher:
Date:
2022-06
Series:
Copyright:
Public Domain
Retrieved From:
Centers for Disease Control and Prevention: https://www.cdc.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations